Clinical Trials Directory

Trials / Completed

CompletedNCT03482661

Magnetic Steering Improves Small Bowel Capsule Endoscopy Completion Rate

Magnetic Steering of Capsule Endoscopy Improves Small Bowel Capsule Endoscopy Completion Rate

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
227 (actual)
Sponsor
Zhuan Liao · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Patients referred for magnetically controlled capsule endoscopy (MCE) in the participating center from June 2017 to November 2017 were prospectively enrolled. Magnetic steering of MCE was performed after standard gastric examination. Capsule endoscopy completion rate (CECR), gastric transit time (GTT), pyloric transit time (PTT) and rapid gastric transit rate (GTT ≤ 30 min) were compared with the historical control group enrolled from January 2017 to May 2017.

Detailed description

Background and aims: Capsule endoscopy is currently available as a noninvasive and effective diagnostic modality to identify small bowel abnormalities, while the completion rate ranged from 75.1% to 95.6%. A novel magnetically controlled capsule endoscopy (MCE) system could facilitate the capsule to pass through pylorus thereby reducing the gastric transit time (GTT). The investigators perform this study to determine the potential improvement in capsule endoscopy completion rate (CECR) under magnetic steering vs standard mode. Methods: Patients referred for magnetically controlled capsule endoscopy (MCE) in the participating center from June 2017 to November 2017 were prospectively enrolled. Magnetic steering of MCE was performed after standard gastric examination. Capsule endoscopy completion rate (CECR), gastric transit time (GTT), pyloric transit time (PTT) and rapid gastric transit rate (GTT ≤ 30 min) were compared with the historical control group enrolled from January 2017 to May 2017.

Conditions

Interventions

TypeNameDescription
OTHERmagnetic steeringThe capsule was controlled to pass through the pylorus by magnet steering.

Timeline

Start date
2017-06-01
Primary completion
2017-11-30
Completion
2017-11-30
First posted
2018-03-29
Last updated
2018-05-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03482661. Inclusion in this directory is not an endorsement.